Palopegteriparatide

Yorvipath (palopegteriparatide) is a prescription medication injected under the skin to treat osteoporosis in certain adults. It works by mimicking parathyroid hormone to help build bone strength. Available in solution form with doses like 0.168 mg or 0.42 mg per cartridge. Manufactured by Ascendis Pharma, Endocrinology, Inc. This information was generated using AI and is provided for informational and research purposes only.